William R. Larue, Director at Tracon Pharmaceuticals, Inc. (TCON), sold 2,500 shares at $2.69 ($7K) on 2017-06-02, disclosed to the SEC on 2017-06-05.
Scheduled sale ($7k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CADX | SELL | 2013-12-18 | $78K | — | Filing → |
| CADX | SELL | 2013-11-18 | $263K | — | Filing → |
| CADX | SELL | 2013-07-17 | $65K | — | Filing → |